Treatment of sarcoidosis – pentoxifylline

D. Semotiuk (Lviv, Ukraine), O. Tolokh (Lviv, Ukraine), N. Rudnitska (Lviv, Ukraine)

Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Session: Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Session type: Poster Discussion
Number: 1958
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Semotiuk (Lviv, Ukraine), O. Tolokh (Lviv, Ukraine), N. Rudnitska (Lviv, Ukraine). Treatment of sarcoidosis – pentoxifylline. 1958

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Combination of pentoxifylline and steroids in sarcoidosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 269s
Year: 2005

Pentoxifylline in treatment of pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 433s
Year: 2002

Efficiency of pentoxifylline different doses in sarcoidosis treatment
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008

Meloxicam in treatment of sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 384s
Year: 2001

Comparison of prednisolone and budesonide in the treatment of pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 80s
Year: 2005

High-doses glucocorticosteroid treatment in sarcoidosis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 118s
Year: 2007

Pentoxifylline and reduced doses of steroids combination in pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 110s
Year: 2007

Treatment and management of cardiac sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018

Corticosteroid treatment in sarcoidosis
Source: Eur Respir J 2006; 28: 627-636
Year: 2006



Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005

Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015


Idiopathic pulmonary fibrosis treatment: Combined pirfenidone + acetylcysteine vs N-acetylcysteine in monotherapy
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


Pulmonary hypertension associated with sarcoidosis and experience of treatment with pentoxifylline (Vasonite)
Source: Eur Respir J 2006; 28: Suppl. 50, 426s
Year: 2006

Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Therapy with low dose methotrexate plus diprospan in patient with recalcitrant recidivating sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 541s
Year: 2006

Rituximab in the treatment of refractory pulmonary sarcoidosis
Source: Eur Respir J 2014; 43: 1525-1528
Year: 2014


Safety of corticosteroid therapy in patients with pulmonary sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017


Safety and efficacy of prolonged treatment of fibrosing alveolitis in scleroderma with cyclophosphamide
Source: Eur Respir J 2005; 26: Suppl. 49, 266s
Year: 2005

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
Source: Eur Respir J, 52 (2) 1800230; 10.1183/13993003.00230-2018
Year: 2018